Comparison of PCO Between a 1- and 3-Piece MICS IOL

Article

Modifications of haptic design yields benefits

Despite the high standard of modern cataract surgery, posterior capsular opacification (PCO) still remains the most frequent longterm complication. Several new foldable multi- or single piece IOLs with sharp optic edge design have been developed to prevent PCO. Previous studies depict that the presence of a sharp posterior optic edge is crucial for PCO prevention, whereas the IOL material and haptic design may be of less importance.

Due to refinements in phacoemulsification technology, cataract can be removed through incisions smaller than 2 mm in a procedure called microincision cataract surgery (MICS). The benefits of MICS are reduced surgically induced astigmatism, rapid visual rehabilitation and more stable wound construction. The early MICS intraocular lenses showed higher PCO incidence, probably due to hydrophilic acrylic material and deviation from the common 3-piece or 1-piece open-loop haptic designs. Recently hydrophobic acrylic 1-piece and 3-piece IOLs are finally commercially available for microincision cataract surgery.

In a present study, recently published in the British Journal of Ophthalmology,1 we compared the development of PCO as well as the clinical outcome between a 1-piece and a 3-piece MICS IOL. Here we discuss the study, highlighting the benefits of modifying the haptic design of a MICS IOL.

Our prospective randomized patient and examiner-masked clinical trial with intraindividual comparison was performed at the Department of Ophthalmology at the Hietzing Hospital (Vienna, Austria). Forty patients (80 eyes) were recruited consecutively.

Each patient received a 1-piece AF-1 iMICS NY-60 IOL (Hoya, Japan) in 1 eye and a 3-piece AF-1 Y-60H MICS IOL (Hoya) in the contralateral eye to allow intraindividual comparison. In 20 cases, the 1-piece IOL was implanted in the right eye and in 20 cases in the left eye.

Surgery was performed by 1 of 5 experienced surgeons, where the same surgeon operated both eyes of a patient. Cataract surgery was performed as a standardized procedure. In all cases, there was a rhexis-overlap with the IOL optic along the entire circumference at the end of the surgery.

A postoperative examination was performed 1 year after surgery. Uncorrected (UCVA) and best spectacle corrected distance visual acuity (BCVA) were measured using ETDRS charts. Using a standardized evaluation form, the following parameters were assessed subjectively: IOL position and centration, and rhexis-IOL overlap. The amount of anterior capsular opacification (ACO) and of posterior fibrosis (fibrotic PCO) were graded by subjective scale from 0 to 3 (0 = clear capsule, 3 = severe fibrotic opacification). Digital retroillumination photographs were obtained with a digital camera mounted on a modified slitlamp (Carl Zeiss Meditec AG, Jena, Germany) with an external flashlight source, which provides coaxial illumination from the flash pack through a fibreoptic cable to the camera. An automated image analysis software, Automated Quantification of After-Cataract (AQUA), for objective PCO evaluation was used. The program detects the capsulorhexis edge semiautomatically (computer aided). The AQUA software calculates the grade of disorder (entropy) of a bitmap. This value is converted to a score between 0 and 10 (0 = clear capsule, 10 = exceptionally severe PCO).

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
Related Content
© 2025 MJH Life Sciences

All rights reserved.